Suppression of experimental autoimmune uveoretinitis by anti-IL-17 antibody

Current Eye Research

Volumn 34, Issue 4, 2009, Pages 297-303

  Zhang, Rui ^a,b   Qian, Jiang ^a   Guo, Jie ^a   Yuan, Yi Fei ^a   Xue, Kang ^a  

^a FUDAN UNIVERSITY   (China)

^b Department of Ophthalmology ^*  (China)

Author keywords

Antibody; Cytokines; Experimental autoimmune uveoretinitis; IL 17; Treatment

Indexed keywords

CYTOKINE ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 5; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; UNCLASSIFIED DRUG; ANTIBODY; EYE PROTEIN; INTERSTITIAL RETINOL-BINDING PROTEIN; RETINOL BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE UVEORETINITIS; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; IMMUNIZATION; IMMUNOASSAY; INFLAMMATION; LYMPH NODE; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; UVEORETINITIS; ANIMAL; CELL PROLIFERATION; DRUG EFFECT; IMMUNOLOGY; LEWIS RAT; LYMPHOCYTE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RETINITIS; UPREGULATION; UVEITIS;

ANIMALS; ANTIBODIES; AUTOIMMUNE DISEASES; CELL PROLIFERATION; EYE PROTEINS; FEMALE; HYPERSENSITIVITY, DELAYED; INTERFERON-GAMMA; INTERLEUKIN-17; LYMPH NODES; LYMPHOCYTES; RATS; RATS, INBRED LEW; RETINITIS; RETINOL-BINDING PROTEINS; UP-REGULATION; UVEITIS;

EID: 67649662167     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680902741696     Document Type: Article

References (27)

1. Sasamoto Y, Kawano YI, Bouligny R, Wiggert B, Chader GJ, Gery I. Immunomodulation of experimental autoimmune uveoretinitis by intravenous injectionofuveitogenic peptides.Invest Ophthalmol Vis Sci 1992;33:2641-2649.
2. Sasamoto Y, Kotake S, Yoshikawa K, Wiggert B, Gery I, Matsuda H. Interphotoreceptor retinoid-binding protein derived peptide can induce experimental autoimmune uveoretinitis in various rat strains. Curr Eye Res 1994;13:845-849.
3. Mosmann TR, Coffman RL. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
4. Imai Y, Sugita M, Nakamura S, Toriyama S, Ohno S. Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada's disease. Curr Eye Res 2001;22:312-318.
5. Jones LS, Rizzo LV, Agarwal RK, Tarrant TK, Chan CC, Wiggert B, Caspi RR. IFN-gamma-deficient mice develop experimental autoimmune uveitisinthe contextof a deviant effector response. J Immunol 1997;158:5997-6005.
6. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, Kastelein RA, Cua DJ. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005;201:233-240.
7. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006;441:235-238.
8. Bettelli E, Oukka M, Kuchroo VK. TH-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007;8:345-350.
9. Peng Y, Han G, Shao H, Wang Y, Kaplan HJ, Sun D. Characterization of IL-17+ interphotoreceptor retinoid-binding proteinspecific T cells in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 2007;48:4153-4161.
10. Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR. Autoimmune inflammation from the Th17 perspective. Autoimmun Rev 2007;6:169-175.
11. Abe T, Satoh N, Nakajima A, Koizumi T, Tamada M, Sakuragi S. Characterization of a potent uveitopathogenic site derived from rat phosducin. Exp Eye Res 1997;65:703-710.
12. + T cells regulate surgical and postinfectious adhesion formation. J Exp Med 2002;195:1471-1478.
13. Inoki T, Yamagami S, Sakai R, Isobe M, Tsuru T, Kawashima H. Suppression of experimental autoimmune uveoretinitis by anti-alphabeta TCR monoclonal antibody. Jpn J Ophthalmol 2002;46:518-524.
14. Chi W, Zhu X, Yang P, Liu X, Lin X, Zhou H, Huang X, Kijlstra A. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. Invest Ophthalmol Vis Sci 2008;49:3058-3064.
15. Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003;14:155-174.
16. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005;6:1123-1132.
17. Lubberts E. IL-17/Th17 targeting: On the road to prevent chronic destructive arthritis? Cytokine 2008;41:84-91.
18. Yoshimura T, Sonoda KH, Miyazaki Y, Iwakura Y, Ishibashi T, Yoshimura A, Yoshida H. Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis. Int Immunol 2008;20:209-214.
19. Amadi-Obi A, Yu CR, Liu X, Mahdi RM, Clarke GL, Nussenblatt RB, Gery I, Lee YS, Egwuagu CE. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1. Nat Med 2007;13:711-718.
20. Takeuchi M, Yokoi H, Tsukahara R, Sakai J, Usui M. Differentiation of Th1 and Th2 cells in lymph nodes and spleens of mice during experimental autoimmune uveoretinitis. Jpn J Ophthalmol 2001;45:463-469.
21. Cruz A, Khader SA, Torrado E, Fraga A, Pearl JE, Pedrosa J, Cooper AM, Castro AG. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol 2006;177:1416-1420.
22. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005;6:1133-1141.
23. Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: An effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006;24:677-688.
24. Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y, Bowman EP, Sgambellone NM, Chan CC, Caspi RR. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med 2008;205:799-810.
25. Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: The Th17 lineage. Curr Opin Immunol 2006;18:349-356.
26. Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat Med 2007;13:139-145.
27. Xu H, Rizzo LV, Silver PB, Caspi RR. Uveitogenicity is associated with a Th1-like lymphokine profile: Cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Cell Immunol 1997;178:69-78.